Mobility tests offer clues, not predictions, on healthy ageing: experts

A poor result is a reason to investigate, not a prediction of how long you'll live.
Experts caution that mobility test scores reveal specific weaknesses, not lifespan or overall aging trajectories.
Mark

So these tests are everywhere now—people doing them at home, posting their scores online. Are they actually useful, or is it just wellness theater?

Mimi

They're useful, but not in the way people think. They're diagnostic, not predictive. A test tells you something is changing in your body. It doesn't tell you what your future looks like.

Mark

But the Brazilian research showed that people who scored higher lived longer. Doesn't that mean the test predicts lifespan?

Mimi

It showed a correlation in one population over one time period. That's valuable information for researchers, but it doesn't mean the same test works the same way for everyone else. Age, genetics, where you live—all of it matters.

Mark

So if I score poorly, what should I actually do with that information?

Mimi

That's when you see a doctor. A low score is a question, not an answer. It means something needs investigating. Is it your knees? Your heart? Your balance? The test is just the beginning.

Mark

Why do you think people want these tests to be predictive? Why does it matter so much to know?

Mimi

Control, maybe. If you could measure aging, you could fight it. But aging isn't that simple. The tests are honest about what they can and can't do. We're the ones who want them to be more.

  • Mobility tests like Timed Up and Go and the sit-to-stand have gone viral as longevity scorecards, creating pressure on patients to read their own futures in a thirty-second exercise.
  • Brazilian research linking higher sit-to-stand scores to lower mortality risk has fuelled the excitement — but the findings come from a specific population and decade, and do not translate cleanly across age groups or cultures.
  • Researchers and clinicians are pushing back, warning that a test validated for middle-aged Brazilians carries no guaranteed meaning for elderly Americans or anyone with a different medical, genetic, or environmental background.
  • The real tension is between what these tests can do — flag a wobble, a weakness, a cardiovascular strain — and what they cannot: predict when someone will die or how their aging will unfold.
  • Healthcare providers are being urged to treat a poor result not as a verdict but as a prompt — a reason to investigate the root cause of functional decline before it compounds into something harder to address.

Across clinics and social media alike, simple physical tests — rising from a chair, walking a few meters, lowering oneself to the floor — have taken on an outsized cultural weight, promising glimpses into how long we might live. Experts in aging medicine are gently but firmly correcting that misreading: these assessments are diagnostic lanterns, not oracles. They illuminate where the body is struggling, and in doing so, they invite the deeper question of why — a question only a clinician, not a stopwatch, can begin to answer.

Your doctor asks you to stand from a chair as many times as possible in thirty seconds, or to lower yourself cross-legged to the floor and rise again without using your hands. These tests have become fixtures in aging medicine — and, increasingly, in social media culture — framed as windows into how well you are aging and how much time you might have left. Experts are pushing back. The tests reveal where the body is weakening. They do not reveal when it will give out.

The most common clinical version is the Timed Up and Go: a patient stands from a chair, walks three metres, and returns. In those few seconds, a doctor can assess balance, mobility, and lower body strength simultaneously. The sit-to-stand test is more elaborate, with a ten-point scoring system that deducts for using hands or showing unsteadiness. It gained particular attention after Brazilian studies in 2020 and 2025 found that middle-aged people who scored higher were less likely to die within roughly a decade — a striking finding, though one that comes with significant caveats about population specificity and generalisability.

Auriel Willette, a brain aging researcher at Rutgers University, puts it plainly: a poor or declining result is a reason for a health professional to investigate why function is changing, not a gauge of how long someone will live. Dr. George Hennawi of MedStar Health in Baltimore echoes this, explaining that every such test is designed to pinpoint a specific weakness — a troubled knee, an inner ear problem, a heart struggling to pump efficiently — and trace it back to its root cause.

The deeper caution is about the limits of extrapolation. A test validated in one population does not automatically apply to another. What signals risk in a sixty-year-old may mean something entirely different in an eighty-year-old. The human body ages along pathways shaped by genetics, environment, healthcare access, and history — variables no single score can capture. The value of these tests lies not in the number they produce, but in the questions they prompt a clinician to ask next.

Your doctor asks you to stand up from a chair as many times as you can in thirty seconds. Or perhaps to lower yourself to the floor cross-legged, then rise again without using your hands. These tests have become fixtures in aging medicine, circulated on social media as windows into how well you're aging, how much longer you might have. But experts are pushing back against that narrative. The tests do something useful—they reveal where your body is weakening. They do not, however, tell you when you will die.

Strength and mobility assessments can measure real things: your stamina, your capacity to resist falls, your overall physical resilience. For doctors, they serve as diagnostic tools. A person who struggles to rise from a chair might have knee pain, weak quadriceps, or cardiovascular strain. A person who wobbles during a balance test might have inner ear problems or neurological changes. The tests are designed to narrow down the question, not answer it. "A poor or declining result is a reason for a health professional to investigate why function is changing, rather than gauging how long someone will live," according to Auriel Willette, a researcher at Rutgers University who studies brain aging.

The most common test in American clinics is called Timed Up and Go. A patient sits in a chair, stands, walks three meters, and returns to the seat. In those few seconds, a doctor can assess balance, mobility, and lower body strength all at once. It's efficient and revealing. Another test, popularized recently on social media, is more elaborate: you move from standing to sitting cross-legged on the ground, then back to standing. The scoring is precise—five points for getting down, five for getting up, with deductions for using your hands or showing unsteadiness. A perfect score is ten. Zero means you cannot do it without help.

The sit-to-stand test has generated particular interest because of research from Brazil. In studies published in 2020 and 2025, researchers found that middle-aged people who scored higher on the test were less likely to die within roughly a decade. The finding is intriguing. It is also limited. American doctors have not widely adopted this particular test with older adults, and the results come from a specific population studied in a specific way. What holds true for middle-aged Brazilians may not hold true for seventy-year-old Americans, or for people with different medical histories, different activity levels, different genetic backgrounds.

This is where the caution matters most. Experts emphasize that the validity of any test depends entirely on the population in which it was studied and verified. If a test has been shown to predict outcomes for one age group, the performance standards do not automatically transfer to another. A score that signals risk for a sixty-year-old may mean something entirely different for an eighty-year-old. A test validated in one country may not apply in another. The human body ages differently depending on genetics, environment, access to healthcare, and countless other variables.

Dr. George Hennawi, who treats older adults at MedStar Health in Baltimore, explains that all these tests share a common purpose: they are meant to pinpoint specific weaknesses and trace them back to their root cause. Is the problem in the knees? The reflexes? The sense of balance? The heart's ability to pump blood efficiently? Each test can help answer a different piece of that puzzle. But none of them is a crystal ball. They are tools for investigation, not prophecy. The value lies not in the score itself, but in what the score prompts a doctor to do next—to ask why, to dig deeper, to address the underlying problem before it worsens.

A poor or declining result is a reason for a health professional to investigate why function is changing, rather than gauging how long someone will live.
— Auriel Willette, brain aging researcher at Rutgers University
All the tests are meant to pinpoint specific weaknesses and narrow down their underlying cause, whether that's knee pain, slow reflexes, poor balance or cardiovascular issues.
— Dr. George Hennawi, MedStar Health, Baltimore
Contáctanos FAQ